About Sepragen
Sepragen is a company based in Hayward (United States) founded in 1987.. Sepragen has raised $5 million across 3 funding rounds from investors including National Science Foundation. The company has 19 employees as of December 31, 2022. Sepragen offers products and services including QuantaSep® Systems, SuperFlo® Columns, and SepraFlo® Resins. Sepragen operates in a competitive market with competitors including ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others.
- Headquarter Hayward, United States
- Employees 19 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sepragen Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5 M (USD)
in 3 rounds
-
Latest Funding Round
$5 M (USD), Series A
Sep 25, 2024
- Investors
-
Employee Count
19
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sepragen
Sepragen offers a comprehensive portfolio of products and services, including QuantaSep® Systems, SuperFlo® Columns, and SepraFlo® Resins. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated multi-use systems for cGMP purification in bioprocessing
Radial flow columns for high-throughput biological separations
Process-scale resins for efficient molecule separation in manufacturing
Unlock access to complete
Funding Insights of Sepragen
Sepragen has successfully raised a total of $5M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $5.0M
-
First Round
First Round
(01 Jul 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series A - Sepragen | Valuation |
investors |
|
| Jun, 2017 | Amount | Grant - Sepragen | Valuation |
investors |
|
| Jul, 2013 | Amount | Grant - Sepragen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sepragen
Sepragen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sepragen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sepragen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sepragen Comparisons
Competitors of Sepragen
Sepragen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Upfront Chromatography, Sepax Technologies, Natrix Separations and Reach Separations, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| domain | founded_year | HQ Location |
Chromatography technologies for protein separation and biomolecule recovery are provided.
|
|
| domain | founded_year | HQ Location |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| domain | founded_year | HQ Location |
Provider of proprietary filtration solutions for life science
|
|
| domain | founded_year | HQ Location |
Small molecule analysis and purification services are provided using chromatography.
|
|
| domain | founded_year | HQ Location |
Microchip liquid chromatography cartridges are supplied for nano-LC applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sepragen
Frequently Asked Questions about Sepragen
When was Sepragen founded?
Sepragen was founded in 1987 and raised its 1st funding round 26 years after it was founded.
Where is Sepragen located?
Sepragen is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Is Sepragen a funded company?
Sepragen is a funded company, having raised a total of $5M across 3 funding rounds to date. The company's 1st funding round was a Grant of $250K, raised on Jul 01, 2013.
How many employees does Sepragen have?
As of Dec 31, 2022, the latest employee count at Sepragen is 19.
What does Sepragen do?
Sepragen Corporation was founded in 1987 and is headquartered in Hayward, United States. Operations focus on the biotechnology sector, where products such as bioreactors, chromatography systems, resins, and columns are developed and manufactured. These enable large-scale separation and production of biotech drugs, nutritional products, and beverages. Radial flow chromatography columns are utilized, along with automated buffer dilution systems and disposable benchtop chromatography systems.
Who are the top competitors of Sepragen?
Sepragen's top competitors include ChromaTan, Sepax Technologies and Semba Biosciences.
What products or services does Sepragen offer?
Sepragen offers QuantaSep® Systems, SuperFlo® Columns, and SepraFlo® Resins.
Who are Sepragen's investors?
Sepragen has 1 investor. Key investors include National Science Foundation.